Efficacy of miglustat in Korean patients with Niemann-Pick disease type C
Objective: The first two Korean patients in siblings of adolescent/adult onset NP-C were evaluated for the efficacy of miglustat. Background: Niemann-Pick disease type C (NP-C)…Validation of the MDS Research Criteria for Prodromal Parkinson’s Disease: longitudinal assessment in a REM sleep behavior disorder (RBD) cohort
Objective: 1) To calculate diagnostic accuracy of the Movement Disorder Society (MDS) prodromal criteria to predict conversion to Parkinson’s disease (PD) or dementia with Lewy…Development of utility to evaluate a symptomatic diary of motor fluctuations of Parkinson’s disease (PD) using a smartphone application.
Objective: To investigate the utility of a symptomatic diary of motor fluctuations of Parkinson's disease (PD) using a smartphone application. Background: In the conference last…Evaluating the Experience of Diagnosis in Parkinson’s Disease
Objective: To evaluate a newly-designed diagnosis patient pathway for Parkinson’s disease, in terms of quality measures and patient satisfaction. Background: Receiving a diagnosis of Parkinson’s…Epilepsy and Cranial nerve affection in a Patient with Wilson’s disease and Intracranial developmental venous anomaly; A Case Report
Objective: 1.present unusual and rare clinical presentations in the disease spectrum2.study Intracranial developmental venous anomalies (DVAs) presentations both clinically and radiologically in Wilson’s disease and their…Vitamin D and Clinical Phenotypes of Parkinson’s Disease
Objective: To explore the relationship of clinical phenotypes of Parkinson's disease (PD) with vitamin D levels in Veterans diagnosed with PD. Background: PD is a heterogeneous neurodegenerative…Preventing Levodopa Induced Dyskinesia with Docosohexanoid Acid in Parkinson Disease
Objective: The purpose of this study was to determine if Docosohexanoic acid (DHA) affects the speed and severity of development of levodopa induced dyskinesia (LID) in subjects starting levodopa (LD).…How will new technology change deep brain stimulation programming?
Objective: Assess the ways in which decision support tools and directional leads are affecting DBS programming. Background: The typical approach to DBS programming has changed…A prospective comparison of apomorphine, STN deep brain stimulation and levodopa-carbidopa intestinal gel therapy for motor fluctuations in PD
Objective: To compare the clinical, functional and quality of life (QoL) outcomes in patients with advanced Parkinson’s disease (PD) following treatment with apomorphine (APO), either…Multi-modal retention in a phase III clinical trial in early Parkinson disease (STEADY-PD III)
Objective: To evaluate novel retention strategies in an ongoing phase 3 clinical trial in individuals with Parkinson disease (PD) Background: Adequate participant retention is a…
- « Previous Page
- 1
- …
- 142
- 143
- 144
- 145
- 146
- …
- 155
- Next Page »